The protein expression levels of MYEOV, GPRC5A, and KRAS showed a consistent trend in pancreatic cancer tissues and normal tissues adjacent to pancreatic cancer from three pancreatic cancer patients. This evidence concerns the gene MYEOV and familial pancreatic carcinoma.